273 related articles for article (PubMed ID: 10469456)
21. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
[TBL] [Abstract][Full Text] [Related]
22. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.
Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA
Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331
[TBL] [Abstract][Full Text] [Related]
23. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
Keen AJ; Knowles MA
Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.
Williams SV; Sibley KD; Davies AM; Nishiyama H; Hornigold N; Coulter J; Kennedy WJ; Skilleter A; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 2002 May; 34(1):86-96. PubMed ID: 11921286
[TBL] [Abstract][Full Text] [Related]
25. Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line.
Fujiwara H; Emi M; Nagai H; Ohgaki K; Imoto I; Akimoto M; Ogawa O; Habuchi T
J Hum Genet; 2001; 46(7):372-7. PubMed ID: 11450846
[TBL] [Abstract][Full Text] [Related]
26. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.
Habuchi T; Luscombe M; Elder PA; Knowles MA
Genomics; 1998 Mar; 48(3):277-88. PubMed ID: 9545632
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel bladder tumour suppressor genes.
Knowles MA
Electrophoresis; 1999 Feb; 20(2):269-79. PubMed ID: 10197433
[TBL] [Abstract][Full Text] [Related]
28. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
Cairns P; Tokino K; Eby Y; Sidransky D
Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242
[TBL] [Abstract][Full Text] [Related]
29. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.
Yang X; Shen P; Yao K; Mi Z; Liu S; Zhang H; Wang D; Liu C; Liu H
Chin Med J (Engl); 2000 Feb; 113(2):117-9. PubMed ID: 11775532
[TBL] [Abstract][Full Text] [Related]
30. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
[TBL] [Abstract][Full Text] [Related]
31. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
32. Role of chromosome 9 in human bladder cancer.
Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
[TBL] [Abstract][Full Text] [Related]
33. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
[TBL] [Abstract][Full Text] [Related]
34. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.
Cappellen D; Gil Diez de Medina S; Chopin D; Thiery JP; Radvanyi F
Oncogene; 1997 Jun; 14(25):3059-66. PubMed ID: 9223669
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
Bell SM; Zuo J; Myers RM; Knowles MA
Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
[TBL] [Abstract][Full Text] [Related]
36. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
37. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
[TBL] [Abstract][Full Text] [Related]
38. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.
Merlo A; Gabrielson E; Mabry M; Vollmer R; Baylin SB; Sidransky D
Cancer Res; 1994 May; 54(9):2322-6. PubMed ID: 8162574
[TBL] [Abstract][Full Text] [Related]
39. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
40. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.
Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV
Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
